VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 111 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53 | -30.3% | 12,155 | +6.4% | 0.00% | – |
| Q2 2023 | $76 | +7.0% | 11,429 | +10.1% | 0.00% | – |
| Q1 2023 | $71 | -100.0% | 10,380 | -97.2% | 0.00% | -100.0% |
| Q1 2015 | $3,400,000 | -94.8% | 365,628 | -92.0% | 0.00% | -92.9% |
| Q4 2014 | $65,517,000 | +53.8% | 4,575,221 | +11.5% | 0.01% | +55.6% |
| Q3 2014 | $42,605,000 | -23.2% | 4,104,521 | +19.8% | 0.01% | -25.0% |
| Q2 2014 | $55,445,000 | +94.8% | 3,426,791 | +95.6% | 0.01% | +100.0% |
| Q1 2014 | $28,468,000 | -5.1% | 1,751,881 | -27.5% | 0.01% | +100.0% |
| Q4 2013 | $29,992,000 | +11661.6% | 2,416,802 | +10317.2% | 0.00% | – |
| Q3 2013 | $255,000 | -44.3% | 23,200 | -59.0% | 0.00% | – |
| Q2 2013 | $458,000 | – | 56,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,532,000 | $27,423,000 | 3.23% |
| Stonepine Capital Management, LLC | 300,000 | $5,370,000 | 3.16% |
| Palo Alto Investors LP | 4,155,670 | $74,386,000 | 3.13% |
| GREAT POINT PARTNERS LLC | 497,531 | $8,906,000 | 1.73% |
| Avoro Capital Advisors LLC | 988,270 | $17,690,000 | 1.37% |
| UNIVERSITY OF NOTRE DAME DU LAC | 157,781 | $2,824,000 | 0.79% |
| Birchview Capital, LP | 68,000 | $1,217,000 | 0.63% |
| Cheyne Capital Management (UK) LLP | 74,000 | $1,323,000 | 0.48% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 352,604 | $6,311,000 | 0.43% |
| 361 CAPITAL LLC | 119,554 | $2,140,000 | 0.41% |